Analyst Ratings for Arcturus Therapeutics (ARCT) [Buys]
ARCT Rating Summary
ARCT Price Target Summary
- Highest: $87.00 (Canaccord Genuity)
- Lowest: $40.00 (Citi)
- Average: $64.80
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$64.80 (+149.4%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
Avg. $ Target:
$64.80 (+149.4%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 64%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/13/2023 | Canaccord Genuity » Updated 3/11/2024 |
Whitney Ijem | New Coverage | Buy (N/A) |
87.00 (81.00) |
23.39 (25.98) |
11.07% | Details |
| 7/24/2023 | William Blair | Myles R. Minter | New Coverage | Outperform (N/A) |
N/A (N/A) |
33.84 (25.98) |
-23.23% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
